US5928940A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Morphogen-responsive signal transducer and methods of use thereof
Assignee: Creative Biomolecules Inc
•
Filing: 1996-10-08
•
Granted: 1999-07-27
•
Expires: 2016-10-08
Abstract
Abstract A novel gene, DD-10, and its encoded polypeptide chain, DD-10, expressed during early onset of morphogen-induced mammalian tissue morphogenesis, now has been discovered. Accordingly, the invention identifies a new gene which is a novel biological marker of cell differentiation and tissue morphogenesis, particularly of chondroblast or osteoblast cell differentiation and bone tissue morphogenesis. Disclosed are: (a) methods and compositions for screening for and producing morphogen analogs; (b) novel morphogen analogs; (c) downstream inducers of morphogenesis; (d) a novel marker for evaluating morphogen or morphogen analog dosing; and (e) therapeutic methods and compositions using these analogs and/or downstream inducers.
Inventors
- 👤 Kuber T. Sampath
- 👤 Kohsuke Takeda
- 👤 Hidenori Ichijo
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-29 22:39
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/475; C07K14/51; A; A61; A61P; A61P19/00; A61K; A61K38/00
Claims Analysis
Total Claims: 39
Claim 1
Independent Claim
12 words
An isolated nucleic acid comprising nucleotides 905-1264 of SEQ ID NO: 1.
Claim 2
Dependent Claim
12 words
An isolated nucleic acid comprising nucleotides 905-1264 of SEQ ID NO: 1.
Claim 3
Dependent Claim
15 words
An isolated nucleic acid comprising nucleotides 121-780, 600-900, or 1-904 of SEQ ID NO: 1.
Claim 4
Dependent Claim
15 words
An isolated nucleic acid comprising nucleotides 121-780, 600-900, or 1-904 of SEQ ID NO: 1.
Claim 5
Dependent Claim
14 words
An isolated nucleic acid comprising nucleotides 1-1264 or 1-3611 of SEQ ID NO: 1.
Claim 6
Dependent Claim
14 words
An isolated nucleic acid comprising nucleotides 1-1264 or 1-3611 of SEQ ID NO: 1.
Claim 7
Dependent Claim
27 words
An isolated nucleic acid selected from the group consisting of aliclic, biosynthetic, species, and recombinant variants of a nucleic acid according to claim 1, 2, or 3.
Claim 8
Dependent Claim
19 words
A fragment of a nucleic acid according to claim 1, said fragment encoding a polypeptide having DD-10 biological activity.
Claim 9
Dependent Claim
32 words
A nucleic acid which hybridizes to the DNA shown in SEQ ID NO: 1 or the complementary strand thereof, wherein said nucleic acid, or the complementary strand thereof, encodes a DD-10 polypeptide.
Claim 10
Dependent Claim
32 words
A nucleic acid which hybridizes to the DNA shown in SEQ ID NO: 1 or the complementary strand thereof, wherein said nucleic acid, or the complementary strand thereof, encodes a DD-10 polypeptide.
Claim 11
Dependent Claim
22 words
A vector comprising nucleotides 905-1264, 121-780, 600-900, 1-904, 1-1264, 1-3611, or 1264-3611 of SEQ ID NO: 1, or a biologically-active fragment thereof.
Claim 12
Dependent Claim
22 words
A vector comprising nucleotides 905-1264, 121-780, 600-900, 1-904, 1-1264, 1-3611, or 1264-3611 of SEQ ID NO: 1, or a biologically-active fragment thereof.
Claim 13
Dependent Claim
27 words
A cell transfected with a nucleic acid comprising nucleotides 905-1264, 121-780, 600-900, 1-904, 1-1264, 1-3611, or 1264-3611 of SEQ ID NO: 1, or a biologically-active fragment thereof.
Claim 14
Dependent Claim
27 words
A cell transfected with a nucleic acid comprising nucleotides 905-1264, 121-780, 600-900, 1-904, 1-1264, 1-3611, or 1264-3611 of SEQ ID NO: 1, or a biologically-active fragment thereof.
Claim 15
Dependent Claim
9 words
A cell transformed with a vector of claim 7.
Claim 16
Independent Claim
91 words
A method for identify a compound that induces a morphogen-mediated biological effect, the method comprising the steps of. a) determining a basal level of expression of a DD-10 genetic sequence in a sample; b) exposing said sample to a candidate compound; c) determining a test level of expression of a DD-10 genetic sequence; and d) comparing said DD-10 test level obtained in step c) with said basal level; wherein a compound that induces a morphogen-mediated biological effect is identified as one that induces a DD-10 test level above said basal level.
Claim 17
Independent Claim
91 words
A method for identify a compound that induces a morphogen-mediated biological effect, the method comprising the steps of. a) determining a basal level of expression of a DD-10 genetic sequence in a sample; b) exposing said sample to a candidate compound; c) determining a test level of expression of a DD-10 genetic sequence; and d) comparing said DD-10 test level obtained in step c) with said basal level; wherein a compound that induces a morphogen-mediated biological effect is identified as one that induces a DD-10 test level above said basal level.
Claim 18
Dependent Claim
23 words
The method according to claim 10 wherein said DD-10 genetic sequence is complementary to SEQ ID NO: 1, or the complementary strand thereof.
Claim 19
Dependent Claim
43 words
The method according to claim 11 wherein said DD-10 genetic sequence comprises a nucleic acid selected from the group consisting of nucleotides 1-904 of SEQ ID NO: 1, nucleotides 600-900 of SEQ ID NO: 1, and nucleotides 121-780 of SEQ ID NO: 1.
Claim 20
Dependent Claim
19 words
The method according to claim 11 wherein said DD-10 genetic sequence is in operative association with a reporter gene.
Claim 21
Dependent Claim
29 words
The method according to claim 10 wherein the level of expression of said DD-10 genetic sequence is determined by detecting an expression product comprising an RNA or a polypeptide.
Claim 22
Dependent Claim
21 words
The method according to claim 14 wherein said RNA is transcribed from the nucleic acid shown in SEQ ID NO: 1.
Claim 23
Dependent Claim
23 words
The method according to claim 14 wherein said polypeptide is the DD-10 polypeptide shown in SEQ ID NO: 2, or a fragment thereof.
Claim 24
Dependent Claim
23 words
The method according to claim 10 wherein said test level of expression is determined 1 to 30 h ours following said exposing step.
Claim 25
Dependent Claim
22 words
The method according to claim 10 wherein said test level of expression is determined 2 to 10 hours following said exposing step.
Claim 26
Dependent Claim
16 words
The method according to claim 10 wherein said morphogen-mediated biological effect is an OP-1-mediated biological effect.
Claim 27
Dependent Claim
16 words
The method according to claim 10 wherein said sample comprises cells having a receptor for OP-1.
Claim 28
Independent Claim
44 words
A method for inducing a morphogen-mediated biological response, said method comprising the step of contacting a precursor cell with a DD-10 nucleic acid under conditions sufficient to obtain expression of said nucleic acid, wherein expression of said nucleic acid induces a morphogen-mediated biological response.
Claim 29
Independent Claim
44 words
A method for inducing a morphogen-mediated biological response, said method comprising the step of contacting a precursor cell with a DD-10 nucleic acid under conditions sufficient to obtain expression of said nucleic acid, wherein expression of said nucleic acid induces a morphogen-mediated biological response.
Claim 30
Dependent Claim
21 words
The method according to claim 21 wherein said precursor cell is a myoblast cell or a cell of the myoblast/chondroblast/osteoblast lineage.
Claim 31
Dependent Claim
14 words
The method according to claim 21 wherein said precursor cell is an osteoblast cell.
Claim 32
Dependent Claim
27 words
The method according to claim 21 wherein said DD-10 nucleic acid hybridizes to a nucleic acid shown in SEQ ID NO: 1 or the complementary stand thereof.
Claim 33
Independent Claim
38 words
A method for detecting a morphogen-mediated biological effect comprising the step of detecting an expression product of a nucleic acid of SEQ ID NO: 1, wherein detection of said expression product is indicative of a morphogen-mediated biological effect.
Claim 34
Independent Claim
38 words
A method for detecting a morphogen-mediated biological effect comprising the step of detecting an expression product of a nucleic acid of SEQ ID NO: 1, wherein detection of said expression product is indicative of a morphogen-mediated biological effect.
Claim 35
Dependent Claim
15 words
The method according to claim 25 wherein said biological effect is chondroblast or osteoblast differentiation.
Claim 36
Dependent Claim
16 words
The method according to claim 25 wherein said expression product is an RNA or a polypeptide.
Claim 37
Dependent Claim
19 words
An oligonucleotide complementary to at least 8 contiguous nucleotides of SEQ ID NO: 1, or the complementary strand thereof.
Claim 38
Dependent Claim
19 words
An oligonucleotide complementary to at least 8 contiguous nucleotides of SEQ ID NO: 1, or the complementary strand thereof.
Claim 39
Dependent Claim
9 words
An oligonucleotide of claim 28 consisting of 10-30 nucleotides.
References Cited (Backward Citations)
EP0148155A2
Cited
WO1990003733A1
Cited
US5106626A
Cited
WO1991002744A1
Cited
EP0416578A2
Cited
WO1992015323A1
Cited
WO1993005172A1
Cited
US5585479A
Cited
WO1994003200A1
Cited
WO1994006399A1
Cited
US5578708A
Cited
WO1996038590A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2002-07-26 | 2003-01-25 | 2003-07-27 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2006-07-26 | 2007-01-25 | 2007-07-27 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2010-07-26 | 2011-01-25 | 2011-07-27 | $7700.00 | Window Closed / Lapsed |